Yosemite's Beverly Lu, Ph.D. joins Ten63's Board of Directors
Ten63 TherapeuticsTen63 Therapeutics, a company combining generative AI and physics-based models to develop first- and best-in-class therapeutics with an internal pipeline focused on oncology, is pleased to announce its partnership with newly unveiled cancer-focused venture fund, Yosemite.